Enumeral Biomed Cash Flow - Quarterly (OTCMKTS:ENUMQ)

Add to My Stocks
$0 $0 (0%) ENUMQ stock closing price May 31, 2018 (Closing)

For analyzing any company like Enumeral Biomed from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Enumeral Biomed profits and Enumeral Biomed debt. Enumeral Biomed stock analysis shows negative net income cash flow of $-5.72M till 2017 Q3. This statement is important because profits alone cannot pay employees, or bills. Cash is required. The cash from operating activities for Enumeral Biomed is $ 2017 Q3, which saw a decrease from previous quarter.

View and download details of Enumeral Biomed cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-5.72M-5.15M-2.01M-11.85M-4.16M-2.9M-1.55M3.29M
Depreciation Depletion Amortization Cash-Flow---1.11M----
Net Increase (Decrease) in Assets Liabilities----0.09M-0.1M---0.08M
Cash From (used in) Discontinued Operations--------
Other Adjustments Net---5.16M-0.34M-0.22M-0.34M-13.11M
Net Cash from (used by) Operating Activities
-3.44M-2.8M-1.67M-5.67M-4.05M-2.34M-1.69M-9.28M
Increase (Decrease) in Prop Plant And Equipment--0.02M-0.02M-----1.05M
Acquisition Disposition of Subsidiaires--------
Increase (Decrease) in Investments-------3.02M
Other Cash Inflow (Outflow) from Investment Activities--------
Net Cash from (used by) Investment Activities
--0.02M-0.02M----1.97M
Issuance (Purchase) of Equity Shares---2.94M----
Issuance (Repayment) of Debt Securities-0.21M-0.21M-0.06M2.28M2.35M-0.11M-0.05M-
Increase (Decrease) in Bank & Other Borrowings--------
Payment of Dividends & Other Cash Distributions--------
Other Cash from (used by) Financing Activities--------
Net Cash from (used by) Financing Activities
---0.06M5.23M2.35M-0.11M-0.05M-
Effect of Exchange Rate Changes on Cash--------
Net Change in Cash & Cash Equivalents
-2.95M-2.58M-1.76M-0.43M-1.7M-2.46M-1.75M-6.86M
Cash & Equivalents at Beginning of Year10.46M-1.74M-----
Cash & Equivalents at Year End--1.4M3.16M1.89M1.13M1.83M3.59M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Shire financial analysis

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Enumeral Biomed stock price history and Enumeral Biomed stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Enumeral Biomed is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Enumeral Biomed stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-3.44M for ENUMQ.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for ENUMQ till last quarter 2017 Q3 report.
  • Cash flow from financing activities shows the flow of cash between Enumeral Biomed and its owners and creditors and was $- till 2017 Q3. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Enumeral Biomed Cash Flow

Quarterly Cash Flow Statements For ENUMERAL BIOMEDICA COM USD0.001 Peers

Shire cash flow